504 related articles for article (PubMed ID: 27876435)
1. Bioinspired approaches for cancer nanotheranostics.
Evangelopoulos M; Tasciotti E
Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
[No Abstract] [Full Text] [Related]
2. Supramolecular Nanotheranostics.
Chen X; Zheng G; Cheng J; Yang YY
Theranostics; 2019; 9(11):3014-3016. PubMed ID: 31244939
[TBL] [Abstract][Full Text] [Related]
3. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy.
Muthu MS; Mehata AK; Viswanadh MK
Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815
[No Abstract] [Full Text] [Related]
4. Facile Supramolecular Approach to Nucleic-Acid-Driven Activatable Nanotheranostics That Overcome Drawbacks of Photodynamic Therapy.
Li X; Yu S; Lee D; Kim G; Lee B; Cho Y; Zheng BY; Ke MR; Huang JD; Nam KT; Chen X; Yoon J
ACS Nano; 2018 Jan; 12(1):681-688. PubMed ID: 29232105
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
6. Artificial Molecular Machines in Nanotheranostics.
Yu G; Yung BC; Zhou Z; Mao Z; Chen X
ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247
[TBL] [Abstract][Full Text] [Related]
7. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice?
Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W
Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
9. Activatable Theranostics.
Huang P
Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459
[No Abstract] [Full Text] [Related]
10. Nanomaterials for theranostics: recent advances and future challenges.
Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
[No Abstract] [Full Text] [Related]
11. Nanohybrids - cancer theranostics for tiny tumor clusters.
Dhandapani R; Sethuraman S; Subramanian A
J Control Release; 2019 Apr; 299():21-30. PubMed ID: 30797000
[TBL] [Abstract][Full Text] [Related]
12. Theranostic application of nanoemulsions in chemotherapy.
Gorain B; Choudhury H; Nair AB; Dubey SK; Kesharwani P
Drug Discov Today; 2020 Jul; 25(7):1174-1188. PubMed ID: 32344042
[TBL] [Abstract][Full Text] [Related]
13. Lipoproteins for therapeutic delivery: recent advances and future opportunities.
Raut S; Dasseux JL; Sabnis NA; Mooberry L; Lacko A
Ther Deliv; 2018 Mar; 9(4):257-268. PubMed ID: 29495929
[TBL] [Abstract][Full Text] [Related]
14. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
Kundu P; Singh D; Singh A; Sahoo SK
Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
[TBL] [Abstract][Full Text] [Related]
15. A biomimetic theranostic O
Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ
Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
Mohammadi M; Ramezani M; Abnous K; Alibolandi M
Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
[TBL] [Abstract][Full Text] [Related]
17. Two-Dimensional Nanomaterials for Cancer Nanotheranostics.
Chen Y; Wu Y; Sun B; Liu S; Liu H
Small; 2017 Mar; 13(10):. PubMed ID: 28075057
[TBL] [Abstract][Full Text] [Related]
18. Fe
Li Y; Zhang H
Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317
[TBL] [Abstract][Full Text] [Related]
19. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
20. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
Sharma R; Mody N; Agrawal U; Vyas SP
Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
